Researchers from the University of Melbourne and Monash University have received $5.4 million from the Victorian government to establish the Victorian mRNA Innovation Hub (VMIH), to advance the technologies involved in mRNA vaccines and therapeutics production that proved pivotal in responding to the COVID-19 pandemic.
Read More
Victoria’s new restrictions follow changes in vaccine manufacturing
Victoria has eased restrictions for masks and working from home settings as the public health ministration highlighted the goals towards a fully vaccinated state.
Read More
Read More
Ginkgo Bioworks to help grow mRNA vaccine capability in Victoria
Synthetic biology company, Ginkgo Bioworks, will establish an office in Melbourne to bolster Victoria’s focus in mRNA research and manufacturing.
Read More
Read More